Organigram reports Q1 revenue $97.3M, consensus $73.15M

Reports Q1 adjusted EBITDA $5.3M vs. $1.4M a year ago. “As I step into the role of CEO, I’m encouraged by the strength of Organigram (OGI) and our leadership position in Canada,” said James Yamanaka, CEO of Organigram. “Over the past 25 days, I’ve toured our facilities and met with many of my new colleagues. What’s clear is that we have a competitive core business, supported by a foundation of innovation and plant science, alongside a continued focus on improving efficiency and scale. As our international presence grows, disciplined execution and operating efficiency will drive profitability.” “Year over year, we delivered strong revenue growth and improved profitability, reflecting the scale we’ve built across the business,” said Greg Guyatt, CFO. “Despite expected seasonal and market dynamics early in the year, adjusted gross margin remained elevated due to greater operational efficiency, higher flower yields, synergies gained from the integration of Motif, and higher international sales. We expect this trend to continue throughout Fiscal 2026, where we project further international sales growth.”